Emily Hayes[email protected]InfectiousBottlenecks in testing supplies short-circuit U.S. COVID-19 responseGiroir, who is the assistant secretary for health at the U.S. Department of Health and Human Services, has been the face of the Trump administration's response on diagnostic testing to the coronavirus pandemic. But during a special session at the AACC 2020 meeting, which is being held in a virtual format from December 13-17, he said he's not one for Washington-style jargon.December 15, 2020Previous PagePage 2 of 2Top StoriesFDA ClearanceAmgen gets FDA approval for small cell lung cancer therapyAmgen announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved its therapy tarlatamab, to be marketed under the name Imdelltra, for the treatment of extensive-stage small cell lung cancer (ES-SCLC).Artificial IntelligenceBacklog of unresolved medical diagnoses leads to new method for clinical exome reanalysisStockT2 Biosystems to sell $8M in stock in private placementFDA Warning LetterFDA issues warning for Cue Health COVID-19 testsSponsor ContentVisit our Molecular Diagnostics Community